Drug Profile
TEA 0769
Alternative Names: TEA-0769Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Bacterial infections in Japan (unspecified route)
- 15 Jun 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 05 Jan 1998 Preclinical development for Bacterial infections in Japan (Unknown route)